Chemoinformaics analysis of 2-Ethyl-5-methylfuran
| Molecular Weight | 110.156 | nRot | 1 |
| Heavy Atom Molecular Weight | 100.076 | nRig | 5 |
| Exact Molecular Weight | 110.073 | nRing | 1 |
| Solubility: LogS | -2.473 | nHRing | 1 |
| Solubility: LogP | 2.701 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 18 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 8 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 7 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 5 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 5 |
| nHA | 1 | APOL | 19.1599 |
| nHD | 0 | BPOL | 11.7681 |
| QED | 0.54 |
| Synth | 1.963 |
| Natural Product Likeliness | -1.239 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.025 |
| HIA | 0.004 |
| CACO-2 | -4.524 |
| MDCK | 0.0000209 |
| BBB | 0.531 |
| PPB | 0.906669 |
| VDSS | 3.53 |
| FU | 0.188904 |
| CYP1A2-inh | 0.973 |
| CYP1A2-sub | 0.947 |
| CYP2c19-inh | 0.669 |
| CYP2c19-sub | 0.891 |
| CYP2c9-inh | 0.227 |
| CYP2c9-sub | 0.781 |
| CYP2d6-inh | 0.139 |
| CYP2d6-sub | 0.881 |
| CYP3a4-inh | 0.037 |
| CYP3a4-sub | 0.521 |
| CL | 9.444 |
| T12 | 0.657 |
| hERG | 0.038 |
| Ames | 0.049 |
| ROA | 0.077 |
| SkinSen | 0.119 |
| Carcinogencity | 0.708 |
| EI | 0.986 |
| Respiratory | 0.106 |
| NR-Aromatase | 0.005 |
| Antiviral | No |
| Prediction | 0.936743 |